EFFECT ·Filed Jul 13, 2026

ONMD

OneMedNet Corp
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago SEC9999999995-26-002260
IPO/offering going effective
Actionable Insight • Neutral

Monitor for a subsequent prospectus or 8-K filing detailing the offering size and pricing. Effectiveness often precedes pricing by 1-2 days for IPOs or follow-ons. The lack of document content limits actionable conclusions; watch for dilution risk if a material secondary offering is disclosed.

DirectionNeutral
Confidencelow
Horizondays
Latest settled — T+20d
ONMD ▼ -11.49% at T+20d
NEUTRAL call ✗ call lost -11.49% · α vs SPY -14.68% · entry $0.7457 → $0.6600
Next anchor: T+60d in 4d
Latest observation: T+56 -2.57% FF3 residual α
Entry anchored
Jul 10, 03:17 PM ET
via exchange tick
T+1d
-2.55%
call -2.55% · α -2.90%
$0.7267
settled 3mo ago
T+5d
-8.84%
call -8.84% · α -8.05%
$0.6798
settled 2mo ago
T+20d
-11.49%
call -11.49% · α -14.68%
$0.6600
settled 8w ago
T+60d
—
call — · α —
—
in 4d

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. OneMedNet Corp (ONMD) filed an EFFECT notice indicating a registration statement has become effective with the SEC. Without the underlying document, the specific offering type (e.g., shelf registration, follow-on) and terms cannot be determined, but the effectiveness typically allows the company to sell securities, creating potential dilution overhang.

Key Facts

  • Filing type: EFFECT — registration statement declared effective by SEC
  • Company: OneMedNet Corp (ONMD), a Nasdaq-listed commercial research services firm with ~$43M market cap
  • Document content was unavailable; specific offering details (size, type, pricing) are unknown

Financial Impact

Undetermined — filing content unavailable

Risk Factors

  • Potential dilution if the effective registration is for a large secondary offering or shelf takedown
  • Uncertainty due to missing document content — terms and timing are unknown

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

Report based on filing metadata.

7 reports for ONMD
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +45.02%Jun 16, 2026
Filters
Rows
Reports for ONMD — sortable, filterable
TypeNow
Jul 24, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$0.6059 $0.5901▼ −2.61%▼ −5.91%$5.39 (+789.59%)
Jul 13, 2026
11w ago
EFFECT
NEUTRAL ★ 3/10
$0.7457 $0.6600▼ −11.49%▼ −14.68%$5.39 (+622.81%)
Jun 17, 2026
15w ago
Insider Cluster
BULLISH ★ 6/10
$0.6023 $0.6901▲ +14.58%▲ +13.26%$5.39 (+794.90%)
Jun 16, 2026
15w ago
Insider Cluster
BULLISH ★ 6/10
$0.5011 $0.7267▲ +45.02%▲ +44.82%$5.39 (+975.63%)
Apr 6, 2026
25w ago
Press Release
BULLISH ★ 8/10
$0.9520 $1.05▲ +10.29%▲ +1.31%$5.39 (+466.18%)
Apr 1, 2026
26w ago
Press Release
NEUTRAL ★ 4/10
$0.8440 $1.08▲ +27.96%▲ +18.24%$5.39 (+538.63%)
Mar 18, 2026
28w ago
Press Release
MIXED ★ 5/10
$0.8190 $0.8870▲ +8.30%▲ +2.26%$5.39 (+558.12%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (38h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access